KHRNF - Khiron Life Sciences Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
1.7813
+0.0913 (+5.40%)
At close: 3:49PM EDT
Stock chart is not supported by your current browser
Previous Close1.6900
Open1.6900
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.6390 - 1.7992
52 Week Range0.6637 - 3.2800
Volume60,752
Avg. Volume236,582
Market Cap185.608M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.3020
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group2 days ago

    Khiron President Chris Naprawa to Participate in Grit Capital Virtual Investor Conference

    TORONTO , June 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, announces today that Company president Chris Naprawa will be presenting at the Grit Capital Virtual Investor Conference to be hosted on June 26, 2019 . Khiron has core operations in Latin America and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis.

  • CNW Group6 days ago

    Grit Capital's Live-Stream Virtual Investor Conference June 26th

    Grit Capital's Live-Stream Virtual Investor Conference June 26th

  • CNW Group8 days ago

    Khiron Completes Acquisition of NettaGrowth International Advancing Multi-Country Operator Strategy

    TORONTO , June 19, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, announces that it has completed the acquisition of NettaGrowth International Inc. ("NettaGrowth"), previously announced on January 25, 2019 and April 9, 2019 , and its wholly-owned subsidiary Dormul S.A. ("Dormul"), a Uruguayan company that has obtained the first licence to produce and export medical cannabis with THC for commercialization in Uruguay . As consideration for the acquisition of NettaGrowth, Khiron has issued 8,498,821 common shares to the shareholders of NettaGrowth at a deemed price of $1.61 per common share.

  • ACCESSWIRE10 days ago

    Khiron Life Sciences Corp. Joins the Stock Day Podcast to Discuss Expansion in Latin America

    PHOENIX, AZ / ACCESSWIRE / June 17, 2019 / The Stock Day Podcast welcomed Khiron Life Sciences Corp. (KHRNF) ("the Company"), a vertically integrated cannabis leader with core operations in Latin America. President of the Company, Chris Naprawa, joined Stock Day host Everett Jolly to discuss the Company's recent closing of a $28 million financing round, and its rapid expansion across new markets. Jolly began the interview by asking about the Company's closing of the aforementioned financing deal.

  • PR Newswire13 days ago

    Khiron Announces Changes to Leadership Team with Appointment of Wendy Kaufman as CFO

    TORONTO, June 14, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, today announced the appointment of Wendy Kaufman as CFO, effective July 2, 2019. Ms. Kaufman, a Chartered Professional Accountant, brings over 20 years of international financial experience, having served most recently as CFO at Pasinex Resources Limited.  Ms. Kaufman has significant experience with Latin American operations, gained during her tenure as CFO at Primero Mining Corporation, and previously in her role as Vice President, Finance and Treasury at Inmet Mining Corporation, among other executive management positions.

  • CNW Group20 days ago

    Khiron Receives Regulatory Approval for Uruguay Acquisition

    TORONTO , June 7, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a medical cannabis company with core operations in Latin America reports that the Company's previously announced agreement for the acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"), is progressing as planned. On June 5, 2019 , the Company secured local regulatory approvals in Uruguay for the completion of the Acquisition.

  • CNW Group21 days ago

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

  • /R E P E A T -- Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year/
    PR Newswire24 days ago

    /R E P E A T -- Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year/

    TORONTO, June 2, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce the completion of construction and the initiation of operations in its cultivation, extraction, and analysis facilities in Ibague, Colombia, where significant progress has been made towards the commercial registration and production of medical cannabis products targeting 6 million potential patients across the country. Khiron currently owns and operates one of the most sophisticated medical cannabis cultivation and processing facilities in Latin America.

  • Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year
    CNW Group25 days ago

    Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year

    TORONTO , June 2, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America , is pleased to announce the completion of construction and the initiation of operations in its cultivation, extraction, and analysis facilities in Ibague, Colombia , where significant progress has been made towards the commercial registration and production of medical cannabis products targeting 6 million potential patients across the country. Khiron currently owns and operates one of the most sophisticated medical cannabis cultivation and processing facilities in Latin America .

  • CNW Group27 days ago

    Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

    Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

  • CNW Group27 days ago

    Khiron Life Sciences Reports First Quarter Fiscal 2019 Financial Results

    Khiron Life Sciences Reports First Quarter Fiscal 2019 Financial Results

  • PR Newswire28 days ago

    Khiron Life Sciences to Webcast Live on June 4th at VirtualInvestorConferences.com

    Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com TORONTO , May 30, 2019 /PRNewswire/ ...

  • CNW Group29 days ago

    Khiron Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF

    TORONTO , May 29, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America is pleased to announce today its addition to the MJ ETFMG Alternative Harvest ETF (MJ) (the "Fund"), a fund with approximately US$1.22 billion in assets currently under management. This represents an important development for the Company as it advances its strategy as a Latin American cannabis company with global growth. The Fund tracks the Prime Alternative Harvest Index, designed to measure the performance of companies within the cannabis ecosystem benefiting from global medicinal and recreational cannabis legalization.

  • CNW Grouplast month

    Khiron Announces Closing of $28.75 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option

    TORONTO , May 28, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America is pleased to announce that it has closed today its previously announced "bought deal" short form prospectus offering of common shares ("Common Shares"), including the exercise in full of the over-allotment option (the "Offering"). A total of 9,914,150 Common Shares were sold at a price of $2.90 per Common Share (the "Issue Price") for aggregate gross proceeds of $28,751,035 (including the exercise in full of the over-allotment option).

  • CNW Grouplast month

    Khiron Provides Update on Transaction to Acquire NettaGrowth

    TORONTO , May 13, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company's previously announced agreement for the acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"), is progressing as planned and the Company is in the latter stages of securing local regulatory approvals in Uruguay for the completion of the Acquisition.

  • CNW Group2 months ago

    Khiron Mails and Files Circular Relating to its Annual General and Special Meeting of Shareholders

    Proxy voting deadline is May 29, 2019 at 11 a.m. ( Toronto time). Board of Directors recommends that Shareholders vote FOR all resolutions. TORONTO , May 10, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a medical cannabis company with core operations in Latin America, today announced it has commenced the mailing of the management information circular and other related materials (collectively, the "Meeting Materials") to Khiron's shareholders ("Shareholders") in connection with the annual general and special meeting of Shareholders (the "Meeting").